fingolimod hydrochloride has been researched along with Optic Nerve Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abouzeid, N; Al-Jumah, M; Alroughani, R; Alsaadi, T; Alsharoqi, I; Bohlega, S; Dahdaleh, M; ElKallab, K; Hashem, S; Inshasi, J; Khoury, S; Tawfeek, T; Yamout, B; Zakaria, M | 1 |
1 other study(ies) available for fingolimod hydrochloride and Optic Nerve Diseases
Article | Year |
---|---|
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Topics: Antibodies, Monoclonal, Humanized; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Middle East; Multiple Sclerosis; Myelitis; Natalizumab; Optic Nerve Diseases; Optic Neuritis; Propylene Glycols; Sphingosine; Spinal Cord Diseases | 2013 |